Overview
Chih-yi Hsu practices practicing medicine in Taipei, Taiwan.
Hsu is highly rated in 3 conditions, according to our data. Their clinical expertise encompasses Triple-Negative Breast Cancer, Breast Cancer, PIK3CA-Related Overgrowth Spectrum, and Syringoma.
They are actively involved in clinical research, co-authoring 80 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Chih-yi Hsu
Is Chih-yi Hsu a top-rated expert for Triple-Negative Breast Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Chih-yi Hsu is classified as an Distinguished expert for Triple-Negative Breast Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Chih-yi Hsu participate in research or clinical trials?
Yes. Chih-yi Hsu has published 80 articles and abstracts on conditions like Triple-Negative Breast Cancer. You can view a list of Chih-yi Hsu's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Triple-Negative Breast CancerHsu isDistinguished. Learn about Triple-Negative Breast Cancer.
- Advanced
- Breast CancerHsu isAdvanced. Learn about Breast Cancer.
- PIK3CA-Related Overgrowth Spectrum
- Experienced
- AcrospiromaHsu isExperienced. Learn about Acrospiroma.
- Adenoid Cystic CarcinomaHsu isExperienced. Learn about Adenoid Cystic Carcinoma.
- AstrocytomaHsu isExperienced. Learn about Astrocytoma.
- B-Cell LymphomaHsu isExperienced. Learn about B-Cell Lymphoma.
- Brain TumorHsu isExperienced. Learn about Brain Tumor.
- GangliogliomaHsu isExperienced. Learn about Ganglioglioma.
- GlioblastomaHsu isExperienced. Learn about Glioblastoma.
- GliomaHsu isExperienced. Learn about Glioma.
- Gliomatosis CerebriHsu isExperienced. Learn about Gliomatosis Cerebri.
- Hemophagocytic Lymphohistiocytosis
- HistiocytosisHsu isExperienced. Learn about Histiocytosis.
- Non-Hodgkin LymphomaHsu isExperienced. Learn about Non-Hodgkin Lymphoma.
- Non-Langerhans-Cell Histiocytosis
- ReticulohistiocytomaHsu isExperienced. Learn about Reticulohistiocytoma.
- SyringomaHsu isExperienced. Learn about Syringoma.
- Thyroid CancerHsu isExperienced. Learn about Thyroid Cancer.